Literature DB >> 16244473

What are gene patents and why are people worried about them?

Jon F Merz1, Mildred K Cho.   

Abstract

This article examines what it means to patent a gene. Numerous ethical concerns have been raised about the effects of such patents on clinical medical practice as well as on research and development. We describe what kinds of inventions are covered by human gene patents, give several examples and summarize the small body of empirical research performed in the US examining the effects of these patents. There is little evidence that early fears about gene patenting placing substantial restraints on research and clinical medicine have come to fruition. Nonetheless, there are areas of concern, and policy makers, physicians and the public should be alert to ensure that the net social benefits of patenting human genes are maintained. Copyright 2005 S. Karger AG, Basel

Entities:  

Keywords:  Biomedical and Behavioral Research; Genetics and Reproduction

Mesh:

Year:  2005        PMID: 16244473      PMCID: PMC2220018          DOI: 10.1159/000087956

Source DB:  PubMed          Journal:  Community Genet        ISSN: 1422-2795


  17 in total

Review 1.  Patenting human genetic material: refocusing the debate.

Authors:  T Caulfield; E R Gold; M K Cho
Journal:  Nat Rev Genet       Date:  2000-12       Impact factor: 53.242

2.  Disease Gene Patenting Is a Bad Innovation.

Authors: 
Journal:  Mol Diagn       Date:  1997-12

3.  France challenges patent for genetic screening of breast cancer.

Authors:  A Dorozynski
Journal:  BMJ       Date:  2001-09-15

4.  Diagnostic testing fails the test.

Authors:  Jon F Merz; Antigone G Kriss; Debra G B Leonard; Mildred K Cho
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

5.  Medical practice and gene patents: a personal perspective.

Authors:  Debra G B Leonard
Journal:  Acad Med       Date:  2002-12       Impact factor: 6.893

6.  Gene patents and the standard of care.

Authors:  Richard Gold; Timothy A Caulfield; Peter N Ray
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

7.  Genetics. DNA patenting and licensing.

Authors:  Michelle R Henry; Mildred K Cho; Meredith A Weaver; Jon F Merz
Journal:  Science       Date:  2002-08-23       Impact factor: 47.728

8.  Balancing innovation and access to healthcare through the patent system--an Australian perspective.

Authors:  Dianne Nicol
Journal:  Community Genet       Date:  2005

9.  Disease genes are not patentable: a rebuttal of McGee.

Authors:  J F Merz; M K Cho
Journal:  Camb Q Healthc Ethics       Date:  1998       Impact factor: 1.284

10.  Disease gene patents: overcoming unethical constraints on clinical laboratory medicine.

Authors:  J F Merz
Journal:  Clin Chem       Date:  1999-03       Impact factor: 8.327

View more
  6 in total

1.  It's about scientific secrecy, dummy: a better equilibrium among genomics patenting, scientific research and health care.

Authors:  Miriam Bentwich
Journal:  Sci Eng Ethics       Date:  2011-02-13       Impact factor: 3.525

Review 2.  Gene patents: a broken incentives system.

Authors:  Yun-Han Huang
Journal:  J Relig Health       Date:  2013-12

3.  Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.

Authors:  Kenneth Offit; Angela Bradbury; Courtney Storm; Jon F Merz; Kevin E Noonan; Rebecca Spence
Journal:  J Clin Oncol       Date:  2013-06-13       Impact factor: 44.544

4.  Recombinant laccase rPOXA 1B real-time, accelerated and molecular dynamics stability study.

Authors:  Leidy D Ardila-Leal; Pedro A Monterey-Gutiérrez; Raúl A Poutou-Piñales; Balkys E Quevedo-Hidalgo; Johan F Galindo; Aura M Pedroza-Rodríguez
Journal:  BMC Biotechnol       Date:  2021-06-04       Impact factor: 2.563

5.  Integrating stakeholder perspectives into the translation of cell-free fetal DNA testing for aneuploidy.

Authors:  Lauren C Sayres; Megan Allyse; Mildred K Cho
Journal:  Genome Med       Date:  2012-06-21       Impact factor: 11.117

6.  Transparency tools in gene patenting for informing policy and practice.

Authors:  Osmat A Jefferson; Deniz Köllhofer; Thomas H Ehrich; Richard A Jefferson
Journal:  Nat Biotechnol       Date:  2013-12       Impact factor: 54.908

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.